Novo Nordisk
NVO
#15
Rank
NZ$910.05 B
Marketcap
$206.10
Share price
-5.46%
Change (1 day)
29.07%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: NZ$910.05 Billion

As of September 2024 Novo Nordisk has a market cap of NZ$910.05 Billion. This makes Novo Nordisk the world's 15th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novo Nordisk from 1996 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$910.05 B24.78%
2023NZ$729.30 B52.06%
2022NZ$479.60 B28.77%
2021NZ$372.45 B64.26%
2020NZ$226.74 B9.94%
2019NZ$206.23 B23.79%
2018NZ$166.60 B-9.77%
2017NZ$184.63 B35.81%
2016NZ$135.95 B-38.97%
2015NZ$222.77 B55.17%
2014NZ$143.56 B16.52%
2013NZ$123.20 B11.04%
2012NZ$110.95 B29.82%
2011NZ$85.47 B-2.76%
2010NZ$87.89 B56.56%
2009NZ$56.14 B-0.59%
2008NZ$56.47 B3.99%
2007NZ$54.30 B44.21%
2006NZ$37.65 B41.29%
2005NZ$26.65 B5.55%
2004NZ$25.25 B16.07%
2003NZ$21.75 B13.17%
2002NZ$19.22 B-42.57%
2001NZ$33.47 B20.02%
2000NZ$27.89 B59.02%
1999NZ$17.54 B-4.11%
1998NZ$18.29 B-1.91%
1997NZ$18.65 B87.9%
1996NZ$9.92 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Novo Nordisk was reported to be:

NZ$910.05 Billion
by Yahoo Finance info icon info icon
NZ$910.05 Billion
by CompaniesMarketCap info icon info icon
NZ$919.89 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$269.47 B-70.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.341 T 47.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$161.91 B-82.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$233.51 B-74.34%๐Ÿ‡ซ๐Ÿ‡ท France